drugset / Trial / NCT01357265

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

NCT01357265

Phase 2 Completed 125 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study will evaluate safety and immunogenicity of a sub-unit Influenza vaccine when administered to adult and elderly subjects.

Timeline

Start
2011-05
Primary completion
2011-05
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Quadrivalent influenza vaccine Vaccine Intramuscular

Indications